110 related articles for article (PubMed ID: 15178639)
81. Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases.
Danielli M; Thomas RC; Quinn LM; Tan BK
Vasa; 2022 Nov; 51(6):341-350. PubMed ID: 36200383
[No Abstract] [Full Text] [Related]
82. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.
Lyles GA
Int J Biochem Cell Biol; 1996 Mar; 28(3):259-74. PubMed ID: 8920635
[TBL] [Abstract][Full Text] [Related]
83. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology.
Boomsma F; Bhaggoe UM; van der Houwen AM; van den Meiracker AH
Biochim Biophys Acta; 2003 Apr; 1647(1-2):48-54. PubMed ID: 12686107
[TBL] [Abstract][Full Text] [Related]
84. Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.
Dunkel P; Gelain A; Barlocco D; Haider N; Gyires K; Sperlágh B; Magyar K; Maccioni E; Fadda A; Mátyus P
Curr Med Chem; 2008; 15(18):1827-39. PubMed ID: 18691041
[TBL] [Abstract][Full Text] [Related]
85. Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes.
Callingham BA; Crosbie AE; Rous BA
Prog Brain Res; 1995; 106():305-21. PubMed ID: 8584667
[TBL] [Abstract][Full Text] [Related]
86. Some aspects of the pharmacology of semicarbazide-sensitive amine oxidases.
Callingham BA; Holt A; Elliott J
J Neural Transm Suppl; 1990; 32():279-90. PubMed ID: 2128500
[TBL] [Abstract][Full Text] [Related]
87. Amine oxidase substrates for impaired glucose tolerance correction.
Carpéné C; Bour S; Visentin V; Pellati F; Benvenuti S; Iglesias-Osma MC; García-Barrado MJ; Valet P
J Physiol Biochem; 2005 Jun; 61(2):405-19. PubMed ID: 16180339
[TBL] [Abstract][Full Text] [Related]
88. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation.
Jalkanen S; Salmi M
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):18-26. PubMed ID: 17962625
[TBL] [Abstract][Full Text] [Related]
89. Properties and functions of tissue-bound semicarbazide-sensitive amine oxidases in isolated cell preparations and cell cultures.
Lyles GA; Pino R
J Neural Transm Suppl; 1998; 52():239-50. PubMed ID: 9564623
[TBL] [Abstract][Full Text] [Related]
90. [Endogenous formaldehyde and cardiovascular diseases].
Zhang FW; Du JB; Tang CS
Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):17-21. PubMed ID: 21417009
[TBL] [Abstract][Full Text] [Related]
91. Semicarbazide-sensitive amine oxidase: current status and perspectives.
Mátyus P; Dajka-Halász B; Földi A; Haider N; Barlocco D; Magyar K
Curr Med Chem; 2004 May; 11(10):1285-98. PubMed ID: 15134520
[TBL] [Abstract][Full Text] [Related]
92. Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.
Salmi M; Jalkanen S
Antioxid Redox Signal; 2019 Jan; 30(3):314-332. PubMed ID: 29065711
[No Abstract] [Full Text] [Related]
93. Vascular adhesion protein-1 and microvascular diabetic complications.
Singh AD; Kulkarni YA
Pharmacol Rep; 2022 Feb; 74(1):40-46. PubMed ID: 35001320
[TBL] [Abstract][Full Text] [Related]
94. Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases.
Li H; Du S; Niu P; Gu X; Wang J; Zhao Y
Front Pharmacol; 2021; 12():679707. PubMed ID: 34322017
[TBL] [Abstract][Full Text] [Related]
95. Cell surface monoamine oxidases: enzymes in search of a function.
Jalkanen S; Salmi M
EMBO J; 2001 Aug; 20(15):3893-901. PubMed ID: 11483492
[TBL] [Abstract][Full Text] [Related]
96. [Vascular adhesion protein-1: an unusual adhesion molecule].
Madej A; Reich A; Szepietowski J
Postepy Hig Med Dosw (Online); 2005; 59():172-9. PubMed ID: 15928600
[TBL] [Abstract][Full Text] [Related]
97. Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors.
Carpéné C; Boulet N; Chaplin A; Mercader J
Medicines (Basel); 2019 Jan; 6(1):. PubMed ID: 30650583
[No Abstract] [Full Text] [Related]
98. Human Copper-Containing Amine Oxidases in Drug Design and Development.
Vakal S; Jalkanen S; Dahlström KM; Salminen TA
Molecules; 2020 Mar; 25(6):. PubMed ID: 32178384
[TBL] [Abstract][Full Text] [Related]
99. VAP-1: an adhesin and an enzyme.
Salmi M; Jalkanen S
Trends Immunol; 2001 Apr; 22(4):211-6. PubMed ID: 11274927
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
